<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04805424</url>
  </required_header>
  <id_info>
    <org_study_id>2020-06151</org_study_id>
    <nct_id>NCT04805424</nct_id>
  </id_info>
  <brief_title>Techniques for Abdominoplasty After Massive Weight Loss</brief_title>
  <official_title>Different Techniques for Abdominoplasty After Massive Weight Loss: Safety and Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Excess skin on the abdomen is a common problem for many individuals after massive weight&#xD;
      loss. The surgical procedure of abdominoplasty is intended to remove excess skin and improve&#xD;
      the shape of the torso in abdomen, in order to address issues such as skin fold eczema,&#xD;
      difficulties finding clothing, and psychosocial issues.&#xD;
&#xD;
      The investigators will conduct a randomized, controlled trial where individuals with excess&#xD;
      skin on the abdomen will be randomized to either standard abdominoplasty or abdominoplasty in&#xD;
      combination with liposuction. The investigators will examine the rate of complications, and&#xD;
      the functional and aesthetical outcomes of the two methods.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">April 2024</completion_date>
  <primary_completion_date type="Anticipated">April 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of and type of complications within 30 days</measure>
    <time_frame>30 days</time_frame>
    <description>Number of and type of complications occurring within 30 days of surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average need for analgesia in morphine equivalents</measure>
    <time_frame>Post-operative day 1</time_frame>
    <description>Average need for analgesia in morphine equivalents during post-operative day 1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average score on BodyQ score</measure>
    <time_frame>At baseline, at 3 months post-operatively, at 12 months post-operatively</time_frame>
    <description>Average score on BodyQ score including subscales. BodyQ is developed and owned by Memorial Sloan Kettering Cancer Center. The BODY-Q is composed of 27 independently functioning scales that measure 3 overarching constructs Appearance, Quality of Life and Experience of Care. Scales are translated to a 0-100 score where a lower score means worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average score on aesthetic result</measure>
    <time_frame>At 12 months post-operatively</time_frame>
    <description>Average score on aesthetic result on a 1-10 scale where a lower score means worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average days until discharge</measure>
    <time_frame>Days</time_frame>
    <description>Average days until discharge post-operatively</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Skin; Excess</condition>
  <arm_group>
    <arm_group_label>Abdominoplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard abdominoplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lipo-abdominoplasty</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Abdominoplasty plus liposuction</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lipo-abdominoplasty</intervention_name>
    <description>Abdominoplasty plus liposuction</description>
    <arm_group_label>Lipo-abdominoplasty</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Abdominoplasty</intervention_name>
    <description>Abdominoplasty</description>
    <arm_group_label>Abdominoplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        This study is open only to individuals who are residents in Sweden and qualify for&#xD;
        government-funded, inpatient, non-emergency health care within the Stockholm Region.&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI &lt; 30&#xD;
&#xD;
          -  Stable BMI for &gt;= 6 months&#xD;
&#xD;
          -  &gt;= 24 months since bariatric surgery, if applicable&#xD;
&#xD;
          -  Skin fold of &gt;= 5 cm&#xD;
&#xD;
          -  Functional and/or psychosocial issues due to abdominal skin excess&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Ongoing infection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ebba Lindqvist, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ebba Lindqvist, MD, PhD</last_name>
    <phone>+46 (0) 8 57 0000</phone>
    <email>ebba.lindqvist@ki.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Reconstructive Plastic Surgery, Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>171 76</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ebba Lindqvist, MD, PhD</last_name>
      <phone>+46 (0) 8 5700000</phone>
      <email>ebba.lindqvist@ki.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 10, 2021</study_first_submitted>
  <study_first_submitted_qc>March 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2021</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska University Hospital</investigator_affiliation>
    <investigator_full_name>Ebba Lindqvist</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Randomized controlled trial</keyword>
  <keyword>Abdominoplasty</keyword>
  <keyword>Massive weight loss</keyword>
  <keyword>Plastic surgery</keyword>
  <keyword>Liposuction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

